Biogen Idec (NQ: BIIB )
202.66
+1.03
(+0.51%)
Streaming Delayed Price
Updated: 1:57 PM EDT, Aug 16, 2024
Add to My Watchlist
All News about Biogen Idec
![](https://cdn.benzinga.com/files/images/story/2024/wall-street-storm-shutter3.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/BIIB_0.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.png?width=1200&height=800&fit=crop)
Breaking Down Biogen: 8 Analysts Share Their Views
February 13, 2024
Via Benzinga
![](https://www.investors.com/wp-content/uploads/2021/07/Stock-biogen-05-shutt.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop)
Looking At Biogen's Recent Unusual Options Activity
February 12, 2024
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/valuestock_image_1.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_3.png?width=1200&height=800&fit=crop)
Critical Insights From Biogen Analyst Ratings: What You Need To Know
January 24, 2024
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2024/data-charts_1.png?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/80f9c524-3da2-4583-a763-0dad931fa182/small/biogen-logo-standard-rgb-r-jpg.jpg)
![](https://investorplace.com/wp-content/uploads/2022/06/millionaire-stocks-to-buy-1600.png)
![](https://cdn.benzinga.com/files/images/story/2023/valuestock_image_0.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Comparing Biogen With Industry Competitors In Biotechnology Industry
January 10, 2024
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image.jpeg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2022/06/biotechnologyepzm1600.png)
![](https://cdn.benzinga.com/files/images/story/2024/AApharma-1.png?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/80f9c524-3da2-4583-a763-0dad931fa182/small/biogen-logo-standard-rgb-r-jpg.jpg)
Biogen to Realign Resources for Alzheimer's Disease Franchise
January 31, 2024
From Biogen Inc.
Via GlobeNewswire
![](https://cdn.benzinga.com/files/images/story/2024/01/29/screenshot_2024-01-29_at_6.57.45_pm.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/01/25/att_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/BIIB.png?width=1200&height=800&fit=crop)
![](https://g.foolcdn.com/editorial/images/762063/mfm_0120.jpg)
![](https://g.foolcdn.com/editorial/images/761429/woman-streaming-on-tv-with-popcorn.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/dementia-Photo-by-Gerd-Altmann-via-Pixab.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/01/10/dna.png?width=1200&height=800&fit=crop)
![](https://www.marketbeat.com/logos/articles/med_20240108072132_2-low-priced-gene-therapy-stocks-to-speculate-on.jpg)
![](https://www.investors.com/wp-content/uploads/2024/01/A1-010824-biotech-Gash.jpg)
![](https://g.foolcdn.com/editorial/images/759989/growth-curve.jpg)
![](https://investorplace.com/wp-content/uploads/2021/11/shutterstock_1667119063.png)
![](https://images.pexels.com/photos/2280549/pexels-photo-2280549.jpeg?auto=compress&cs=tinysrgb&h=750&w=1260)
Government-granted Patent Monopolies Are Not The Free Market
December 29, 2023
Via Talk Markets
Topics
Intellectual Property
Exposures
Intellectual Property
![](https://cdn.benzinga.com/files/images/story/2023/12/29/pills-image_by_steve_buissinne_from_pixabay.jpg?width=1200&height=800&fit=crop)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.